<DOC>
	<DOCNO>NCT02693002</DOCNO>
	<brief_summary>Peri-menopausal woman randomize hormone replacement therapy placebo 12 week determine marker systolic diastolic function change echocardiography well laboratory marker heart failure , include b-type natriuretic peptide ( BNP ) .</brief_summary>
	<brief_title>Estrogen Diastolic Heart Failure</brief_title>
	<detailed_description>This preliminary , feasibility study randomize 28 peri-menopausal woman either hormone replacement therapy placebo 12 week . Prior randomization , participant undergo echocardiography , measurement activity use Duke Activity Status Index , measurement quality life laboratory data , include b-type natriuretic peptide ( BNP ) measurement . Following intervention 12 week , measurement repeat .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>28 healthy recently postmenopausal woman last menstrual bleed 12 month study entry . Women last menstrual bleeding within 12 month study entry perimenopausal drug FDA approve . History hysterectomy , oophorectomy History heart disease include cardiac transplantation , heart failure , bypass surgery percutaneous intervention , valve disease define moderate severe valve regurgitation stenosis History bone disease include nontraumatic vertebral fracture radiography Uncontrolled chronic disease ( include uncontrolled diabetes define hemoglobin A1C &gt; 8 , uncontrolled hypertension define systolic blood pressure &gt; 160 mmHg , await organ transplant ) Previous current cancer , exclude basal cell carcinoma Previous current thromboembolic disease Previous intolerance Hormone replacement therapy ( HRT ) Oral contraception ( OC ) Current previous use HRT within past 3 month Current recent ( &lt; 12 month ) substance abuse , include tobacco use No drug interaction HRT No racial ethnic group exclude</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>